Mohamed, M. et al. 2022. INITIATING/SWITCHING TO INSULIN DEGLUDEC/INSULIN ASPART (IDEGASP) IN MALAYSIAN PATIENTS WITH TYPE 2 DIABETES IN REAL-WORLD SETTING. Journal of the ASEAN Federation of Endocrine Societies. 37, (Jul. 2022), 25.